Well it came back to that 2385. Remember, that's their cover girl. And the NIH said this is very important for this genomic sequencing. Well, two venture funds doing their due diligence came back and found that this particular patent was going to infringe their product. Well, then we had an auct...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login
